What Is HER2 Positive Breast Cancer?

What Is HER2 Positive Breast Cancer?

You may have heard about Breast Cancer that is “HER2 Positive.” Or you may have been recently diagnosed with this kind of Breast Cancer yourself. You have also probably heard all the “bad news” about it. Here are the straight facts about HER2 and, most importantly, what YOU can do about it.

HER2 Defined

HER2 (also called ErbB2, HER2/neu,HER2+, HER2 Overexpression or simply HER2) is a growth-promoting protein. It stands for “Human Epidermal Growth Factor Receptor 2.” In a healthy body, HER2 stimulates normal cell growth and development and is important for cell survival. In adult women, one place that HER2 proteins are located are on the outside of each breast cell.

Genes associated with an excessive expression of HER2 proteins are altered so that high levels of HER2 protein are released. For a woman who has Breast Cancer, the result is often cancer cells which have the potential to divide and multiply rapidly. When conventional test results show heavy amounts of HER2 protein, a woman will be diagnosed with “HER2 Positive Breast Cancer” by her allopathic oncologist. Breast Cancers labeled “HER2-negative” have little or no HER2 proteins.

According to a 2012 study by Emory University in Atlanta, Georgia, over-expression of HER2 proteins exists in roughly 20 to 30 percent of Breast Cancer tumors.

Epigenetics and HER2 Positive Breast Cancer

HER2 Positive Breast Cancer is considered an aggressive form of cancer by traditional medicine. However, just because a woman has this diagnosis does not mean that she does not have a measure of control over this situation.

Conventional medical science still maintains that cancer is a hereditary, genetic disease and external factors have very little to do with its development. In reality, nothing could be farther from the truth.

The burgeoning field of epigenetics is about discovering how “outside factors” such as environmental toxins and chronic stress can influence gene expression.

Read more of this special report from Dr. Véronique Desaulniers.

Related posts